Skip to main content
Erschienen in: European Radiology 6/2015

01.06.2015 | Urogenital

Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology

verfasst von: Lars Boesen, Elizaveta Chabanova, Vibeke Løgager, Ingegerd Balslev, Kari Mikines, Henrik S. Thomsen

Erschienen in: European Radiology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the diagnostic performance of preoperative multiparametric MRI with extracapsular extension (ECE) risk-scoring in the assessment of prostate cancer tumour stage (T-stage) and prediction of ECE at final pathology.

Materials and Methods

Eighty-seven patients with clinically localised prostate cancer scheduled for radical prostatectomy were prospectively enrolled. Multiparametric MRI was performed prior to prostatectomy, and evaluated according to the ESUR MR prostate guidelines by two different readers. An MRI clinical T-stage (cTMRI), an ECE risk score, and suspicion of ECE based on tumour characteristics and personal opinion were assigned. Histopathological prostatectomy results were standard reference.

Results

Histopathology and cTMRI showed a spearman rho correlation of 0.658 (p < 0.001) and a weighted kappa = 0.585 [CI 0.44;0.73](reader A). ECE was present in 31/87 (36 %) patients. ECE risk-scoring showed an AUC of 0.65–0.86 on ROC-curve for both readers, with sensitivity and specificity of 81 % and 78 % at best cutoff level (reader A), respectively. When tumour characteristics were influenced by personal opinion, the sensitivity and specificity for prediction of ECE changed to 61 %–74 % and 77 %-88 % for the readers, respectively.

Conclusions

Multiparametric MRI with ECE risk-scoring is an accurate diagnostic technique in determining prostate cancer clinical tumour stage and ECE at final pathology.

Key Points

Multiparametric MRI is an accurate diagnostic technique for preoperative prostate cancer staging
ECE risk scoring predicts extracapsular tumour extension at final pathology
ECE risk scoring shows an AUC of 0.86 on the ROC-curve
ECE risk scoring shows a moderate inter-reader agreement (K = 0.45)
Multiparametric MRI provides essential knowledge for optimal clinical management
Literatur
1.
Zurück zum Zitat Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124–137CrossRefPubMed Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124–137CrossRefPubMed
2.
Zurück zum Zitat Mullerad M, Hricak H, Kuroiwa K et al (2005) Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174:2158–2163CrossRefPubMed Mullerad M, Hricak H, Kuroiwa K et al (2005) Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174:2158–2163CrossRefPubMed
3.
Zurück zum Zitat Grossfeld GD, Chang JJ, Broering JM et al (2001) Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 165:851–856CrossRefPubMed Grossfeld GD, Chang JJ, Broering JM et al (2001) Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 165:851–856CrossRefPubMed
4.
Zurück zum Zitat Soulié M (2008) What is the role of surgery for locally advanced disease? Eur Urol Suppl 7:400–405CrossRef Soulié M (2008) What is the role of surgery for locally advanced disease? Eur Urol Suppl 7:400–405CrossRef
5.
Zurück zum Zitat Sciarra A, Barentsz J, Bjartell A et al (2011) Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 59:962–977CrossRefPubMed Sciarra A, Barentsz J, Bjartell A et al (2011) Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol 59:962–977CrossRefPubMed
6.
Zurück zum Zitat Fütterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17:1055–1065CrossRefPubMed Fütterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils. Local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17:1055–1065CrossRefPubMed
7.
Zurück zum Zitat Mullerad M, Hricak H, Wang L, Chen H-N, Kattan MW, Scardino PT (2004) Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 232:140–146CrossRefPubMed Mullerad M, Hricak H, Wang L, Chen H-N, Kattan MW, Scardino PT (2004) Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 232:140–146CrossRefPubMed
8.
Zurück zum Zitat Brajtbord JS, Lavery HJ, Nabizada-Pace F, Senaratne P, Samadi DB (2011) Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer. BJU Int 107:1419–1424CrossRefPubMed Brajtbord JS, Lavery HJ, Nabizada-Pace F, Senaratne P, Samadi DB (2011) Endorectal magnetic resonance imaging has limited clinical ability to preoperatively predict pT3 prostate cancer. BJU Int 107:1419–1424CrossRefPubMed
9.
Zurück zum Zitat Hegde JV, Chen M-H, Mulkern RV, Fennessy FM, D’Amico AV, Tempany CMC (2013) Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 85:101–107CrossRef Hegde JV, Chen M-H, Mulkern RV, Fennessy FM, D’Amico AV, Tempany CMC (2013) Preoperative 3-Tesla multiparametric endorectal magnetic resonance imaging findings and the odds of upgrading and upstaging at radical prostatectomy in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 85:101–107CrossRef
10.
Zurück zum Zitat Renard-Penna R, Rouprêt M, Comperat E et al (2013) Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study. Urol Oncol 31:448–454CrossRefPubMed Renard-Penna R, Rouprêt M, Comperat E et al (2013) Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study. Urol Oncol 31:448–454CrossRefPubMed
11.
Zurück zum Zitat Heidenreich A (2011) Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol 59:495–497CrossRefPubMed Heidenreich A (2011) Consensus criteria for the use of magnetic resonance imaging in the diagnosis and staging of prostate cancer: not ready for routine use. Eur Urol 59:495–497CrossRefPubMed
13.
Zurück zum Zitat Portalez D, Mozer P, Cornud F et al (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62:986–996CrossRefPubMed Portalez D, Mozer P, Cornud F et al (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62:986–996CrossRefPubMed
14.
Zurück zum Zitat Röthke M, Blondin D, Schlemmer H-P, Franiel T (2013) PI-RADS classification: structured reporting for MRI of the prostate. Röfo 185:253–261PubMed Röthke M, Blondin D, Schlemmer H-P, Franiel T (2013) PI-RADS classification: structured reporting for MRI of the prostate. Röfo 185:253–261PubMed
15.
Zurück zum Zitat Boesen L, Noergaard N, Chabanova E et al (2014) Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy. Scand J Urol. doi:10.3109/21681805.2014.9 PubMed Boesen L, Noergaard N, Chabanova E et al (2014) Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy. Scand J Urol. doi:10.​3109/​21681805.​2014.​9 PubMed
16.
Zurück zum Zitat Rosenkrantz AB, Kim S, Lim RP et al (2013) Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269:482–492CrossRefPubMed Rosenkrantz AB, Kim S, Lim RP et al (2013) Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269:482–492CrossRefPubMed
17.
Zurück zum Zitat Roethke MC, Kuru TH, Schultze S et al (2014) Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 24:344–352CrossRefPubMed Roethke MC, Kuru TH, Schultze S et al (2014) Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla. Eur Radiol 24:344–352CrossRefPubMed
18.
Zurück zum Zitat Sobin L, Gospodarowicz MWC (2009) TNM classification of malignant tumours. Urological tumours, 7th edn. Wiley-Blackwell, Hoboken Sobin L, Gospodarowicz MWC (2009) TNM classification of malignant tumours. Urological tumours, 7th edn. Wiley-Blackwell, Hoboken
19.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed
20.
Zurück zum Zitat Rosenkrantz AB, Chandarana H, Gilet A et al (2013) Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension. J Magn Reson Imaging 38:312–319CrossRefPubMed Rosenkrantz AB, Chandarana H, Gilet A et al (2013) Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension. J Magn Reson Imaging 38:312–319CrossRefPubMed
21.
Zurück zum Zitat Chong Y, Kim CK, Park SY, Park BK, Kwon GY, Park JJ (2014) Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. AJR Am J Roentgenol 202:772–777CrossRefPubMed Chong Y, Kim CK, Park SY, Park BK, Kwon GY, Park JJ (2014) Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. AJR Am J Roentgenol 202:772–777CrossRefPubMed
22.
Zurück zum Zitat Bloch BN, Furman-Haran E, Helbich TH et al (2007) Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging–initial results. Radiology 245:176–185CrossRefPubMed Bloch BN, Furman-Haran E, Helbich TH et al (2007) Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging–initial results. Radiology 245:176–185CrossRefPubMed
23.
Zurück zum Zitat Fütterer JJ, Engelbrecht MR, Huisman HJ et al (2005) Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237:541–549CrossRefPubMed Fütterer JJ, Engelbrecht MR, Huisman HJ et al (2005) Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237:541–549CrossRefPubMed
24.
Zurück zum Zitat Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek ALM, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302CrossRefPubMed Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek ALM, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302CrossRefPubMed
25.
Zurück zum Zitat Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ et al (2006) Prostate cancer: local staging at 3-T endorectal MR imaging–early experience. Radiology 238:184–191CrossRefPubMed Fütterer JJ, Heijmink SWTPJ, Scheenen TWJ et al (2006) Prostate cancer: local staging at 3-T endorectal MR imaging–early experience. Radiology 238:184–191CrossRefPubMed
26.
Zurück zum Zitat Heijmink SWTPJ, Fütterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T–comparison of image quality, localization, and staging performance. Radiology 244:184–195CrossRefPubMed Heijmink SWTPJ, Fütterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T–comparison of image quality, localization, and staging performance. Radiology 244:184–195CrossRefPubMed
27.
Zurück zum Zitat Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H (2005) Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 95:751–756CrossRefPubMed Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H (2005) Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 95:751–756CrossRefPubMed
28.
Zurück zum Zitat Hsu C-Y, Joniau S, Oyen R, Roskams T, Van Poppel H (2007) Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol 51:121–128, discussion 128–9CrossRefPubMed Hsu C-Y, Joniau S, Oyen R, Roskams T, Van Poppel H (2007) Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol 51:121–128, discussion 128–9CrossRefPubMed
29.
Zurück zum Zitat Mitchell CR, Boorjian SA, Umbreit EC, Rangel LJ, Carlson RE, Karnes RJ (2012) 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer. BJU Int 110:1709–1713CrossRefPubMed Mitchell CR, Boorjian SA, Umbreit EC, Rangel LJ, Carlson RE, Karnes RJ (2012) 20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer. BJU Int 110:1709–1713CrossRefPubMed
30.
Zurück zum Zitat Spahn M, Briganti A, Capitanio U et al (2012) Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease. J Urol 188:84–90CrossRefPubMed Spahn M, Briganti A, Capitanio U et al (2012) Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease. J Urol 188:84–90CrossRefPubMed
31.
Zurück zum Zitat Wang L, Hricak H, Kattan MW, Chen H-N, Scardino PT, Kuroiwa K (2006) Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238:597–603CrossRefPubMed Wang L, Hricak H, Kattan MW, Chen H-N, Scardino PT, Kuroiwa K (2006) Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238:597–603CrossRefPubMed
32.
Zurück zum Zitat Shukla-Dave A, Hricak H, Akin O et al (2012) Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 109:1315–1322CrossRefPubMedCentralPubMed Shukla-Dave A, Hricak H, Akin O et al (2012) Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int 109:1315–1322CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat Ruprecht O, Weisser P, Bodelle B, Ackermann H, Vogl TJ (2012) MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy. Eur J Radiol 81:456–460CrossRefPubMed Ruprecht O, Weisser P, Bodelle B, Ackermann H, Vogl TJ (2012) MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy. Eur J Radiol 81:456–460CrossRefPubMed
34.
Zurück zum Zitat Garcia-Reyes K, Passoni NM, Palmeri ML et al (2014) Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis. Abdom Imaging. doi:10.1007/s00261-014-019 Garcia-Reyes K, Passoni NM, Palmeri ML et al (2014) Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis. Abdom Imaging. doi:10.​1007/​s00261-014-019
35.
Zurück zum Zitat Turkbey B, Merino MJ, Gallardo EC et al (2014) Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 39:1443–1448CrossRefPubMed Turkbey B, Merino MJ, Gallardo EC et al (2014) Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 39:1443–1448CrossRefPubMed
Metadaten
Titel
Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology
verfasst von
Lars Boesen
Elizaveta Chabanova
Vibeke Løgager
Ingegerd Balslev
Kari Mikines
Henrik S. Thomsen
Publikationsdatum
01.06.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 6/2015
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3543-9

Weitere Artikel der Ausgabe 6/2015

European Radiology 6/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.